Assessing glycaemic variability with continuous glucose monitoring system before and after continuous subcutaneous insulin infusion in people with Type 1 diabetes.
We evaluated glycaemic variability with continuous glucose monitoring system in 31 people with Type 1 diabetes mellitus using multiple daily injections initially and after switching to continuous subcutaneous insulin infusion. There was a significant improvement in HbA1c, mean glucose, standard deviation of mean glucose and in hyperglycaemic excursions with CSII.
Chimenti
Elisa Moya
EM
Department of Endocrinology, Hospital Infanta Cristina, Parla, Madrid, Spain. emoyachimenti@gmail.com
de la Morena
Lucrecia Herranz
LH
Vaquero
Pilar Martín
PM
Sáez-de-Ibarra
Lourdes
L
Domínguez
María García
MG
Sánchez
Luis Felipe Pallardo
LF
D001786:Blood Glucose / Q000032:analysis* / Q000378:metabolism; D015190:Blood Glucose Self-Monitoring; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D006442:Glycated Hemoglobin; D055104:Infusions, Subcutaneous; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage*; D007332:Insulin Infusion Systems; D018670:Monitoring, Ambulatory
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007328:Insulin